AI-powered antibody Fc engineering platform for next-gen biologics
Built from URL
Boston
Antibody TherapeuticsArtificial intelligence and machine learningLife SciencesBiotechDrug Discovery
See something off about this company?
Built from URL
Developing biotherapeutics with optimized efficacy, safety, and manufacturability is slow and costly, with high downstream failure rates due to poor translation from computational design to clinical reality.